The Detection of New Adverse Drug Reactions |
Contents
Introduction | 1 |
The Methodology of the Collection of Adverse Event Data | 28 |
Laboratory Investigations | 51 |
Copyright | |
11 other sections not shown
Other editions - View all
The Detection of New Adverse Drug Reactions M. D. B. Stephens,J. C. C. Talbot No preview available - 1988 |
Common terms and phrases
abnormalities ADR reports adverse drug reactions adverse event adverse reactions algorithm aplastic anaemia assessment associated benoxaprofen Captopril causality cause Ciba-Geigy cimetidine Clin clinical trials clinician cohort studies concurrent control COSTART criteria Day Month detect diagnosis disease doctor dose Drug Inf Drug Monitoring Drug Safety drug surveillance Drug-induced edition efficacy evaluation factors further hospital hypertension identified incidence Inman interactions investigations known laboratory data licence marketing Medicines method number of patients occurring onset organised Pharm pharmaceutical company pharmaceutical industry pharmacological Pharmacovigilance Phase physician placebo PMS schemes population possible post-marketing surveillance practolol pre-marketing prescription probably problems protocol published question questionnaire rechallenge record regulatory authorities relevant reporting of adverse risk scale score serious side effects specific spontaneous reports standard statistical suspected adverse suspected drug symptoms Table therapeutic therapy treatment Type volunteers